⌘K
Loading ticker…
Pliant Therapeutics, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Pliant Therapeutics, Inc. Common Stock (PLRX) has a 3-month relative strength percentile of 29 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 45. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 4.2%, relative volume 0.69×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
29 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
PLRX is in a stage 4 downtrend, week 4. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -5.0% / -15.3%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
PLRX is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $2M notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $2M |
| VXFVanguard Extended Market ETF | 0.00% | $706K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PLRX Jan avg: 15.26% median: -0.93% win: 25% σ: 44.77% n: 4 2022-04-12 → 2026-05-29 | PLRX Feb avg: -20.27% median: -10.26% win: 25% σ: 32.91% n: 4 2022-04-12 → 2026-05-29 | PLRX Mar avg: -21.61% median: -11.31% win: 0% σ: 26.72% n: 4 2022-04-12 → 2026-05-29 | PLRX Apr avg: -3.58% median: -3.17% win: 40% σ: 16.23% n: 5 2022-04-12 → 2026-05-29 | PLRX May avg: -7.31% median: -3.92% win: 40% σ: 11.65% n: 5 2022-04-12 → 2026-05-29 | PLRX Jun avg: 0.15% median: -12.72% win: 25% σ: 28.15% n: 4 2022-04-12 → 2026-05-29 (current) | PLRX Jul avg: 43.57% median: 29.49% win: 75% σ: 51.08% n: 4 2022-04-12 → 2026-05-29 | PLRX Aug avg: 2.70% median: 2.81% win: 50% σ: 10.38% n: 4 2022-04-12 → 2026-05-29 | PLRX Sep avg: -3.58% median: -3.52% win: 50% σ: 11.04% n: 4 2022-04-12 → 2026-05-29 | PLRX Oct avg: 10.67% median: 16.28% win: 75% σ: 18.06% n: 4 2022-04-12 → 2026-05-29 | PLRX Nov avg: -9.38% median: -4.74% win: 0% σ: 11.24% n: 4 2022-04-12 → 2026-05-29 | PLRX Dec avg: 1.69% median: 0.30% win: 50% σ: 22.70% n: 4 2022-04-12 → 2026-05-29 |